Nurse Practitioner, Family · Houston, TX
NPI
1942739784
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,459
142 services
Medicare patients, 2024
34
Average age 73
Drug cost, 2024
$2.3M
740 prescriptions
Company payments, 2025
$401
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manila A Pillai was code 99213 (office e&m - established), 70 times for 12 patients. In total Manila A Pillai billed 142 services in 5 codes, and Medicare paid $7,459.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 70 | 12 | $45.31 | $3,172 |
| 99214 Office E&M - Established | Facility | 53 | 28 | $61.73 | $3,271 |
By year: 2022 $6,747 for 116 services; 2023 $4,042 for 67 services; 2024 $7,459 for 142 services.
Medicare prescription drug claims, 2024
In 2024, the drug Manila A Pillai prescribed most often to Medicare patients was Eliquis (Apixaban), with 86 prescriptions and refills. In total Manila A Pillai wrote 740 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 86 | 120 | 19 | $68K |
| Acyclovir Generic | 73 | 95 | 22 | $812 |
| Venclexta Venetoclax | 38 | 38 | Under 11 | $225K |
| Hydroxyurea Generic | 33 | 66 | 11 | $967 |
| Imbruvica Ibrutinib | 31 | 31 | Under 11 | $307K |
| Xarelto Rivaroxaban | 30 | 40 | Under 11 | $21K |
| Dexamethasone Generic | 30 | 39 | Under 11 | $491 |
| Fluconazole Generic | 30 | 30 | Under 11 | $255 |
| Levofloxacin Generic | 25 | 25 | 12 | $439 |
| Promethazine Hcl Generic | 24 | 24 | Under 11 | $136 |
| Allopurinol Generic | 23 | 37 | Under 11 | $109 |
| Revlimid Lenalidomide | 18 | 18 | Under 11 | $331K |
| Valacyclovir Valacyclovir Hcl | 18 | 32 | Under 11 | $1,129 |
| Warfarin Sodium Generic | 18 | 46 | Under 11 | $252 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 23 | Under 11 | $52.18 |
Brand drugs: 306 claims; generic drugs: 434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manila A Pillai $401 ($401 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novartis Pharmaceuticals Corporation with $206.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $206 |
| Daiichi Sankyo Inc. 4568.T | 2 | $58.08 |
| Eisai Inc. 4523.T | 1 | $32.64 |
| Adaptive Biotechnologies Corporation ADPT | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $23.53 |
| Janssen Biotech, Inc. JNJ | 1 | $20.1 |
| Genmab U.S., Inc. GMAB | 1 | $15.73 |
| Exelixis Inc. EXEL | 1 | $15.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.